Syntec Optics Q3 Earnings Call Highlights

Syntec Optics logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Syntec Optics reported record Q3 2026 revenue of about $8.5 million, up 23%, and returned to profitability with net income of approximately $0.2 million, versus a $1.4 million loss a year earlier.
  • Defense and Space led growth: Defense revenue rose 31% to $4.2 million, while Space revenue more than doubled to $1.3 million. After the quarter, production orders for actuator products supporting NASA’s Artemis III rockets increased the Space Tech backlog by 10%.
  • Gross margin expanded to about 23% from 12%, and adjusted EBITDA reached roughly $0.8 million. Syntec ended September with $14.4 million in cash and plans to assess investments in manufacturing capacity, automation and metrology.
  • MarketBeat previews the top five stocks to own by December 1st.

Syntec Optics NASDAQ: OPTX reported record third-quarter 2026 revenue of approximately $8.5 million, up 23% from a year earlier, as growth in defense and space products helped the company return to profitability.

Net income was approximately $0.2 million, or $0.01 per basic and diluted share, compared with a net loss of $1.4 million, or $0.04 per share, in the third quarter of 2025. Operating income was approximately $0.2 million, reversing a $1.2 million operating loss a year earlier.

Chief Financial Officer Dean Rudy said the results reflected progress in operating performance, customer program growth and the company’s financial position. He said Syntec is working to use available manufacturing capacity and expand its role in customer programs as they move toward recurring production.

Defense and space lead growth

Defense Tech remained Syntec’s largest end market, generating approximately $4.2 million in quarterly revenue, up 31% from a year earlier. Space Tech revenue rose 117% to approximately $1.3 million, making it the fastest-growing end market during the quarter. Together, the two categories accounted for approximately 64% of revenue.

Life Sciences revenue increased 12% to approximately $2.7 million, or 31% of the total. AI Data Center and Power and other applications, including scientific instruments, each contributed approximately $200,000, or 2% of revenue.

Syntec began presenting results across the five end-market categories this quarter. Controller Paul Opela said prior-year revenue was reclassified for comparison without changing total revenue or the timing of revenue recognition. The company continues to have one reportable segment under generally accepted accounting principles.

Rudy said third-quarter orders expanded Syntec’s participation in orbital safety and government satellite reconnaissance. After the quarter ended, the company announced production orders for actuator products supporting NASA’s Artemis III rockets. According to Rudy, the order increased Space Tech backlog by 10% and extended the company’s space portfolio into lunar mission hardware.

Margins improve as expenses decline

Gross profit increased 127% to approximately $1.9 million, while gross margin expanded to approximately 23% from 12% a year earlier. The company attributed the improvement to higher revenue accompanied by a comparatively modest increase in the cost of goods sold.

Selling, general and administrative expenses fell by approximately $0.3 million to $1.7 million. Syntec said it continues to target another 10% gain in gross margin, leading to adjusted EBITDA of 20%.

During the financial review, Opela cited adjusted EBITDA of approximately $800,000, or 10% of revenue, compared with negative $16,000 a year earlier. Rudy had earlier cited approximately $0.9 million. Adjusted EBITDA is a non-GAAP measure; the company said its definition and reconciliation to GAAP results are available in its third-quarter Form 10-Q.

Cash position supports investment plans

Syntec ended September with approximately $14.4 million in cash, up from $14 million at the end of June. Operating activities generated approximately $1.3 million during the first nine months of 2026, compared with $0.7 million in the same period a year earlier.

Opela said an equity financing completed earlier in the year and repayment of the company’s revolving line of credit strengthened its financial position. Rudy said Syntec plans to evaluate investments in manufacturing capabilities, automation and metrology based on customer requirements and expected returns.

In life sciences, Rudy pointed to a previously announced $4.6 million follow-on order for blood test cartridges and optical reader subsystems, as well as approximately $4 million of additional recurring orders across applications including surgical robotics and DNA sequencing.

AI Data Center and Power revenue remains modest and has been affected by product transition timing at a major customer, Rudy said. Syntec expects new product launches in early 2027 to support a rebound in the category. Rudy also noted that production ramps, customer orders and tooling milestones will continue to influence quarterly results.

About Syntec Optics (NASDAQ:OPTX)

Syntec Optics designs and manufactures precision optical components, assemblies and systems. Its products include lenses, mirrors, prisms, optical coatings and molded optics, as well as custom optical subassemblies for specialized applications. The company serves customers in markets including defense and security, biomedical technology, communications and consumer products. Its capabilities support applications such as imaging, laser systems and optical communications. Based in Rochester, New York, Syntec Optics traces its operating history to 1981.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Syntec Optics Right Now?

Before you consider Syntec Optics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Syntec Optics wasn't on the list.

While Syntec Optics currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines